Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Clinical trial NCT02514174 · COMPLETED

Trial details

NCT number: NCT02514174
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung ErbB Receptors

Start date: 2015-08-18
Primary completion: 2019-03-28
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.